Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Poolbeg Pharma Share Price
  4. Poolbeg Pharma Share Regulatory News
  5. Poolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology

Pin to quick picksPoolbeg Pharma Regulatory News (POLB)

Poolbeg Pharma Information

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes
Get Live Data
7.65    -0.05 (-0.65%)
Bid:
7.50
Ask:
7.80
Spread: 0.30 (4.00%)
Market Cap: £53.59m
POLB Live PriceLast checked at - London Stock Exchange

Intraday Poolbeg Pharma Share Chart

Poolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology

9 Nov 2022 13:53

Poolbeg Pharma PLC Poolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology 09.11.2022 / 14:51 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

09.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:Poolbeg Pharma PLC
United States
ISIN:GB00BKPG7Z60
EQS News ID:1483443
 
End of NewsEQS News Service

1483443 09.11.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
16th Jun 20267:05 amRNSEuropean patent granted for POLB 001 in CRS
16th Jun 20267:00 amRNSPDMR Notification
11th Jun 20267:05 amRNSPreclinical data posters presented at EHA Congress
11th Jun 20267:00 amRNSPoolbeg Announces POLB 001 TOPICAL Site Activation
9th Jun 20262:32 pmRNSResults of AGM & Change of Registered Address
26th May 20267:00 amRNSPre-IND Meeting with the FDA for POLB 001
13th May 20267:00 amRNSPOLB 001 poster to be presented at EHA 2026
11th May 20267:00 amRNSPOLB 001 CRS patent granted in Canada
7th May 20267:00 amRNSAnnual Report & AGM Notice
28th Apr 20267:00 amRNSResults for the year ended 31 December 2025
15th Apr 20267:00 amRNSMHRA grants CTA for the POLB 001 TOPICAL trial
31st Mar 20267:00 amRNSSignificant milestone for Poolbeg's IP portfolio
12th Mar 20267:00 amRNS-RAppointment of Dr Adrian Kilcoyne to SAB
9th Feb 20263:13 pmRNSNotification of Major Holdings
28th Jan 20267:00 amRNSPOLB 001 LPS Challenge Trial Paper Published
27th Jan 20262:30 pmRNSExercise of Options & Total Voting Rights
18th Dec 20257:00 amRNS-RLetter to Shareholders – 2025 a year of progress
8th Dec 20257:00 amRNS-RPOLB 001 to feature in CRS research programme
20th Nov 20257:00 amRNSPOLB 001 European Patent granted
29th Sep 20257:00 amRNSInterim Results for the six months to 30 June 2025
25th Sep 20257:00 amRNSPOLB 001 Phase 2a Trial Update
1st Jul 20254:24 pmRNSNotification of Major Holdings
26th Jun 20257:00 amRNSNotification of Major Holdings
25th Jun 20258:00 amRNSDirector/PDMR Shareholding
23rd Jun 20252:57 pmRNSResults of GM and AGM Meetings
27th May 20257:01 amRNSFDA Orphan Drug Designation granted for POLB 001
27th May 20257:00 amRNSAnnual Report, AGM Notice & Circular
23rd May 20257:00 amRNSResult of upsized oversubscribed BookBuild Offer
22nd May 20251:44 pmRNSIncrease of BookBuild Offer
20th May 202512:26 pmRNSResult of Placing and Notice of General Meeting
20th May 20257:02 amRNSProposed Retail Offer to raise up to £100,000
20th May 20257:01 amRNSProposed Fundraising to raise approximately £4.1M
20th May 20257:00 amRNSResults for the year ended 31 December 2024
27th Mar 20257:00 amRNS-RConference Participation in March & April 2025
20th Mar 20257:00 amRNS-RPOLB 001 Patent Granted in Korea
25th Feb 20258:50 amRNSForm 8.5 (EPT/NON-RI)
24th Feb 20258:48 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 202511:53 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
21st Feb 20257:00 amRNSTermination of proposed combination with HOOKIPA
20th Feb 20258:06 pmGNWHOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
20th Feb 20259:03 amRNSForm 8.5 Poolbeg Pharma Plc
20th Feb 20258:53 amRNSForm 8.5 (EPT/NON-RI)
20th Feb 20257:49 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
19th Feb 202512:35 pmGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
18th Feb 20255:35 pmRNSHolding(s) in Company
18th Feb 20255:04 pmRNSForm 8.3 - Poolbeg Pharma plc
18th Feb 202510:17 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
17th Feb 202510:28 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
14th Feb 202510:25 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
14th Feb 20259:11 amRNSForm 8.5 Poolbeg Pharma Plc
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
VAL
ValiRx
LSE
0.00%
RSA
RSA.L
LSE
0.00%
JESC
JESC.L
LSE
0.00%
OCDO
Ocado
LSE
-1.48%
DRTY
DRTY.L
LSE
0.00%
Trending
NANO
Nanoco
LSE
17.24%
QHE
Quantum Helium
LSE
6.38%
GST
GSTechnologies
LSE
-4.82%
KEFI
Kefi Gold & Copper
LSE
-0.35%
HEX
Helix Exploration
LSE
-3.23%